Strongyloides stercoralis combined with concurrent multiple pathogens infections in an immunosuppressed patient: a case report.

IF 3.1 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Frontiers in Medicine Pub Date : 2025-01-08 eCollection Date: 2024-01-01 DOI:10.3389/fmed.2024.1519065
Jingchun Fang, Huimin Fang, Penghao Guo, Yaqin Peng, Peisong Chen
{"title":"<i>Strongyloides stercoralis</i> combined with concurrent multiple pathogens infections in an immunosuppressed patient: a case report.","authors":"Jingchun Fang, Huimin Fang, Penghao Guo, Yaqin Peng, Peisong Chen","doi":"10.3389/fmed.2024.1519065","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong><i>Strongyloides stercoralis</i> is an opportunistic pathogenic parasite. Most individuals with normal immune function may not exhibit significant symptoms, and the signs are atypical, which can easily lead to missed diagnoses and delayed treatment. People with underlying diseases and weakened immunity are prone to develop severe conditions after infection with <i>Strongyloides stercoralis</i>.</p><p><strong>Case presentation: </strong>We report an immunocompromised patient in whom the pathogen was initially not detectable using traditional parasitic detection techniques. However, <i>Strongyloides stercoralis</i> was identified in both the alveolar lavage fluid and blood through metagenomic next-generation sequencing. Subsequently, <i>Strongyloides stercoralis</i> was detected in the alveolar lavage fluid after multiple rounds of testing using traditional microscopic examination techniques. Based on the mNGS results and other examination findings, the patient was diagnosed with <i>Strongyloides stercoralis</i> in combination with concurrent multiple pathogens infections. After the combined drug therapy of Meropenem, Vancomycin, and Albendazole, the patient's condition was gradually brought under control.</p><p><strong>Conclusion: </strong>This case demonstrates the advantage of integrating traditional detection methods with metagenomics next-generation sequencing technology in the etiological diagnosis of immunocompromised individuals. It is conducive to clarifying the etiological diagnosis of patients and thereby facilitating the timely initiation of corresponding treatments.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"11 ","pages":"1519065"},"PeriodicalIF":3.1000,"publicationDate":"2025-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11753413/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fmed.2024.1519065","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Strongyloides stercoralis is an opportunistic pathogenic parasite. Most individuals with normal immune function may not exhibit significant symptoms, and the signs are atypical, which can easily lead to missed diagnoses and delayed treatment. People with underlying diseases and weakened immunity are prone to develop severe conditions after infection with Strongyloides stercoralis.

Case presentation: We report an immunocompromised patient in whom the pathogen was initially not detectable using traditional parasitic detection techniques. However, Strongyloides stercoralis was identified in both the alveolar lavage fluid and blood through metagenomic next-generation sequencing. Subsequently, Strongyloides stercoralis was detected in the alveolar lavage fluid after multiple rounds of testing using traditional microscopic examination techniques. Based on the mNGS results and other examination findings, the patient was diagnosed with Strongyloides stercoralis in combination with concurrent multiple pathogens infections. After the combined drug therapy of Meropenem, Vancomycin, and Albendazole, the patient's condition was gradually brought under control.

Conclusion: This case demonstrates the advantage of integrating traditional detection methods with metagenomics next-generation sequencing technology in the etiological diagnosis of immunocompromised individuals. It is conducive to clarifying the etiological diagnosis of patients and thereby facilitating the timely initiation of corresponding treatments.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
粪类圆线虫合并并发多种病原体感染的免疫抑制患者:一个病例报告。
背景:粪圆线虫是一种机会致病性寄生虫。大多数免疫功能正常的个体可能不会表现出明显的症状,而且体征是非典型的,这很容易导致漏诊和延误治疗。患有基础疾病和免疫力较弱的人在感染粪类圆线虫后容易出现严重症状。病例介绍:我们报告了一名免疫功能低下的患者,其中病原体最初无法使用传统的寄生虫检测技术检测到。然而,通过新一代宏基因组测序,在肺泡灌洗液和血液中都发现了粪圆线虫。随后,用传统的显微镜检查技术进行多轮检测后,在肺泡灌洗液中检测到粪圆线虫。根据mNGS结果和其他检查结果,患者被诊断为粪类圆线虫合并并发多种病原体感染。经美罗培南、万古霉素、阿苯达唑联合治疗,患者病情逐渐得到控制。结论:本病例显示了将传统检测方法与新一代宏基因组测序技术相结合在免疫功能低下个体病因诊断中的优势。有利于明确患者的病因诊断,从而便于及时启动相应的治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Frontiers in Medicine
Frontiers in Medicine Medicine-General Medicine
CiteScore
5.10
自引率
5.10%
发文量
3710
审稿时长
12 weeks
期刊介绍: Frontiers in Medicine publishes rigorously peer-reviewed research linking basic research to clinical practice and patient care, as well as translating scientific advances into new therapies and diagnostic tools. Led by an outstanding Editorial Board of international experts, this multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide. In addition to papers that provide a link between basic research and clinical practice, a particular emphasis is given to studies that are directly relevant to patient care. In this spirit, the journal publishes the latest research results and medical knowledge that facilitate the translation of scientific advances into new therapies or diagnostic tools. The full listing of the Specialty Sections represented by Frontiers in Medicine is as listed below. As well as the established medical disciplines, Frontiers in Medicine is launching new sections that together will facilitate - the use of patient-reported outcomes under real world conditions - the exploitation of big data and the use of novel information and communication tools in the assessment of new medicines - the scientific bases for guidelines and decisions from regulatory authorities - access to medicinal products and medical devices worldwide - addressing the grand health challenges around the world
期刊最新文献
Correction: Oregon primary care providers as a frontline defense in the War on Melanoma™: improving access to melanoma education. Correction: Melanoma toolkit for early detection for primary care clinicians: a 1-year follow-up on outcomes. A multi-database pharmacovigilance study reveals distinctive immunosuppressive and opportunistic infection disproportionality signals with bevacizumab and temozolomide combination therapy in glioblastoma. Physicians' opinions on barriers to patient counseling on physical activity in primary care: focus on physicians' healthy exercise habits and knowledge about physical activity. Bridging the gap: a card-based pharmacology resource to support prescribing in undergraduate dental clinical training.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1